Regenerative Medical Technology Group Inc.
RMTG
$0.09
$0.00-4.44%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 309.11% | 93.46% | 4.04% | 19.69% | 23.95% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 309.11% | 93.46% | 4.04% | 19.69% | 23.95% |
| Cost of Revenue | 263.24% | 107.64% | 49.34% | 183.86% | 49.29% |
| Gross Profit | 340.27% | 87.15% | -20.48% | -32.86% | 11.14% |
| SG&A Expenses | 155.89% | 87.23% | 55.58% | 33.22% | 16.76% |
| Depreciation & Amortization | 65.69% | 88.61% | 453.60% | -14.30% | -33.98% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 187.52% | 94.25% | 65.19% | 66.23% | 21.29% |
| Operating Income | 381.03% | 86.15% | -176.06% | -1,921.65% | -10.22% |
| Income Before Tax | -101.27% | -15.30% | -118.24% | -390.78% | 30.48% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -101.27% | -15.30% | -118.24% | -390.78% | 30.48% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -101.27% | -15.30% | -118.24% | -390.78% | 30.48% |
| EBIT | 381.03% | 86.15% | -176.06% | -1,921.65% | -10.22% |
| EBITDA | 538.46% | 86.83% | -144.03% | -408.04% | -44.25% |
| EPS Basic | -90.88% | -10.07% | -111.79% | -390.40% | 30.75% |
| Normalized Basic EPS | -90.69% | -10.03% | -111.95% | -344.12% | 30.70% |
| EPS Diluted | -90.88% | -10.07% | -111.79% | -390.40% | 30.75% |
| Normalized Diluted EPS | -90.69% | -10.03% | -111.95% | -344.12% | 30.70% |
| Average Basic Shares Outstanding | 5.47% | 4.79% | 3.04% | 0.00% | 0.36% |
| Average Diluted Shares Outstanding | 5.47% | 4.79% | 3.04% | 0.00% | 0.36% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |